In this metabolic context, to investigate the impact of IL-18BP deficiency on MASLD/MASH severity, we compared liver phenotype of Il18bp-/-vs. WT mice on HFD (Fig. 4 left panels) and MCD diet (Fig. 4 right panels). This evidence concerns the gene IL18BP and metabolic dysfunction-associated steatotic liver disease.